Literature DB >> 30169544

Correction: ABCC6 plays a significant role in the transport of nilotinib and dasatinib, and contributes to TKI resistance in vitro, in both cell lines and primary patient mononuclear cells.

.   

Abstract

[This corrects the article DOI: 10.1371/journal.pone.0192180.].

Entities:  

Year:  2018        PMID: 30169544      PMCID: PMC6118391          DOI: 10.1371/journal.pone.0203583

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


S1 Table is omitted from the list of Supporting Information. It can be viewed below. S1 File is also omitted from the list of Supporting Information. It can be viewed below. The publisher apologizes for the errors.

Summary of inhibitors used in this study and the corresponding cellular transporters upon which they act.

(DOCX) Click here for additional data file.

Supplementary methods.

(DOCX) Click here for additional data file.
  1 in total

1.  ABCC6 plays a significant role in the transport of nilotinib and dasatinib, and contributes to TKI resistance in vitro, in both cell lines and primary patient mononuclear cells.

Authors:  Laura N Eadie; Phuong Dang; Jarrad M Goyne; Timothy P Hughes; Deborah L White
Journal:  PLoS One       Date:  2018-01-31       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.